After attending two virtual congresses, innovative companies, physicians and specialists in urology once again met in person for the 37th Annual Congress of the European Association of Urology (EAU) in Amsterdam (1–4 July 2022). Together with KARL STORZ, STORZ MEDICAL presented...

STORZ MEDICAL (UK) Ltd., a 100% subsidiary, is celebrating its 20th anniversary. The well-oiled service organisation deals with hospital equipment products, most notably in the fields of urology and stone therapy.

For the very first time, STORZ MEDICAL will be presenting the new semi-stationary solution for SWL and endourology at the 73rd Congress of the Deutsche Gesellschaft für Urologie (DGU, German Society of Urology) in Stuttgart. It consists of the MODULITH® SLK »inline« and the flat-panel detector C-arc STORZ MEDICAL X-FP-S.

The established and US-market leading MODULITH SLX-F2 extracorporeal shock wave lithotripter from STORZ MEDICAL has recently received the FDA 510 (k) clearance for new indications. With this clearance, an absolutely unique selling point for STORZ MEDICAL is that children over the age of three years suffering of stone disease can now be treated non-invasively^{(*1,2, 3)}. The MODULITH SLX-F2 is the first and the only lithotripter available for lithotripsy in children in the USA.